The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
Relapsing and remitting multiple sclerosis: Pathology of the newly forming lesion
Abstract
The study describes the clinical and pathological findings in 12 patients with relapsing and remitting multiple sclerosis, who died during or shortly after the onset of a relapse. Pathological changes not previously associated with the formation of new symptomatic lesions were observed in seven cases, namely, extensive oligodendrocyte apoptosis and microglial activation in myelinated tissue containing few or no lymphocytes or myelin phagocytes. No current laboratory model of multiple sclerosis, in particular, experimental allergic encephalomyelitis, is known with these features, which raises the possibility of some novel process underlying new lesion formation in multiple sclerosis. Ann Neurol 2004;55:000–000
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Axonal transection in the lesions of multiple sclerosis
Trapp, B. D., Peterson, J., Ransohoff, R. M., Rudick, R., Mörk, S., & Bö, L. (1998) · New England Journal of Medicine · doi:10.1056/nejm199801293380502 · Cited by 4,029
Fadok, V. A., Bratton, D. L., Konowal, A., Freed, P. W., Westcott, J. Y., & Henson, P. M. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1112 · Cited by 3,166
Handbook of clinical neurology
(1986) · Journal of Neuroimmunology · doi:10.1016/0165-5728(86)90030-5 · Cited by 1,849
Four deaths and a funeral: from caspases to alternative mechanisms
Leist, M., & Jäättelä, M. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35085008 · Cited by 1,587
Corpse clearance defines the meaning of cell death
Savill, J., & Fadok, V. (2000) · Nature · doi:10.1038/35037722 · Cited by 1,547
Why does remyelination fail in multiple sclerosis?
Franklin, R. J. M. (2002) · Nature Reviews Neuroscience · doi:10.1038/nrn917 · Cited by 837
Tumor necrosis factor identified in multiple sclerosis brain.
Hofman, F. M., Hinton, D. R., Johnson, K., & Merrill, J. E. (1989) · The Journal of experimental medicine · doi:10.1084/jem.170.2.607 · Cited by 801
Microglial cell cytotoxicity of oligodendrocytes is mediated through nitric oxide.
Merrill, J. E., Ignarro, L. J., Sherman, M. P., Melinek, J., & Lane, T. E. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.151.4.2132 · Cited by 781
Distinct Patterns of Multiple Sclerosis Pathology Indicates Heterogeneity in Pathogenesis
Lucchinetti, C. F., Brück, W., Rodriguez, M., & Lassmann, H. (1996) · Brain Pathology · doi:10.1111/j.1750-3639.1996.tb00854.x · Cited by 733
Heterogeneity of multiple sclerosis pathogenesis: implications for diagnosis and therapy
Lassmann, H., Brück, W., & Lucchinetti, C. (2001) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(00)01909-2 · Cited by 627
Cited by
Items 101–135 of 135
Remyelination is altered by bone morphogenic protein signaling in demyelinated lesions
Sabo, J. K., Aumann, T. D., Merlo, D., Kilpatrick, T. J., & Cate, H. S. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.5859-10.2011 · Cited by 93
Experimental models of multiple sclerosis
Pachner, A. R. (2011) · Current Opinion in Neurology · doi:10.1097/wco.0b013e328346c226 · Cited by 90
Marriott, M. P., Emery, B., Cate, H. S., Binder, M. D., Kemper, D., Wu, Q., Kolbe, S., Gordon, I. R., Wang, H., Egan, G., et al. (2008) · Glia · doi:10.1002/glia.20646 · Cited by 86
Cuprizone effect on myelination, astrogliosis and microglia attraction in the mouse basal ganglia
Pott, F., Gingele, S., Clarner, T., Dang, J., Baumgartner, W., Beyer, C., & Kipp, M. (2009) · Brain Research · doi:10.1016/j.brainres.2009.09.084 · Cited by 85
“A decrease of the volume of the globus pallidus has recently been reported (Benedict et al., 2009).”
Merson, T. D., Binder, M. D., & Kilpatrick, T. J. (2010) · NeuroMolecular Medicine · doi:10.1007/s12017-010-8112-z · Cited by 84
Acs, P., Selak, M. A., Komoly, S., & Kalman, B. (2013) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2013.06.012 · Cited by 84
Neurodegeneration Triggers Peripheral Immune Cell Recruitment into the Forebrain
Scheld, M., Rüther, B. J., Große-Veldmann, R., Ohl, K., Tenbrock, K., Dreymüller, D., Fallier-Becker, P., Zendedel, A., Beyer, C., Clarner, T., et al. (2016) · The Journal of Neuroscience · doi:10.1523/jneurosci.2456-15.2016 · Cited by 82
Keller, C. W., Sina, C., Kotur, M. B., Ramelli, G., Mundt, S., Quast, I., Ligeon, L.-A., Weber, P., Becher, B., Münz, C., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1713664114 · Cited by 81
S., P. A. (2006) · doi:10.4049/jimmunol.176.7.4385 · Cited by 80
Starost, L., Lindner, M., Herold, M., Xu, Y. K. T., Drexler, H. C. A., Heß, K., Ehrlich, M., Ottoboni, L., Ruffini, F., Stehling, M., et al. (2020) · Acta Neuropathologica · doi:10.1007/s00401-020-02217-8 · Cited by 79
Zeis, T., Probst, A., Steck, A. J., Stadelmann, C., Brück, W., & Schaeren‐Wiemers, N. (2009) · Brain Pathology · doi:10.1111/j.1750-3639.2008.00231.x · Cited by 76
Rüther, B. J., Scheld, M., Dreymueller, D., Clarner, T., Kress, E., Brandenburg, L., Swartenbroekx, T., Hoornaert, C., Ponsaerts, P., Fallier‐Becker, P., et al. (2017) · Glia · doi:10.1002/glia.23202 · Cited by 76
Hendrickx, D. A. E., Koning, N., Schuurman, K. G., Strien, M. E. V., Eden, C. G. V., Hamann, J., & Huitinga, I. (2013) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31827fd9e8 · Cited by 72
Roles of white matter in central nervous system pathophysiologies
Matute, C., & Ransom, B. R. (2012) · ASN Neuro · doi:10.1042/an20110060 · Cited by 70
“Sensitization by glutamate to complement attack may initiate multiple sclerosis lesions with massive oligodendrocyte apoptosis, as described earlier (Barnett and Prineas, 2004).”
BackgroundFernandez-Castaneda, A., Arandjelovic, S., Stiles, T. L., Schlobach, R. K., Mowen, K. A., Gonias, S. L., & Gaultier, A. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.384693 · Cited by 55
The cuprizone model: regional heterogeneity of pathology
Wergeland, S., Torkildsen, Ø., Myhr, K., Mørk, S. J., & Bø, L. (2012) · APMIS · doi:10.1111/j.1600-0463.2012.02882.x · Cited by 52
Plant, S. R., Iocca, H. A., Wang, Y., Thrash, J. C., O'Connor, B. P., Arnett, H. A., Fu, Y.-X., Carson, M. J., & Ting, J. P.-Y. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.1307-07.2007 · Cited by 51
Palumbo, S., Toscano, C. D., Parente, L., Weigert, R., & Bosetti, F. (2012) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07363.x · Cited by 46
Carlson, N. G., Hill, K. E., Tsunoda, I., Fujinami, R. S., & Rose, J. W. (2006) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2006.01.008 · Cited by 42
Pathogenesis of Multiple Sclerosis: What Can We Learn from the Cuprizone Model
Acs, P., & Kalman, B. (2012) · Methods in Molecular Biology · doi:10.1007/978-1-60761-720-4_20 · Cited by 42
Sun, F., Lin, C. G., Mctigue, D., Shan, X., Tovar, C. A., Bresnahan, J. C., & Beattie, M. S. (2010) · Glia · doi:10.1002/glia.21009 · Cited by 38
Sen, M. K., Almuslehi, M. S. M., Gyengesi, E., Myers, S. J., Shortland, P. J., Mahns, D. A., & Coorssen, J. R. (2019) · Cells · doi:10.3390/cells8111314 · Cited by 35
Vereyken, E. J. F., Fluitsma, D. M., Bolijn, M. J., Dijkstra, C. D., & Teunissen, C. E. (2009) · Glia · doi:10.1002/glia.20852 · Cited by 33
Guglielmetti, C., Levi, J., Huynh, T. L., Tiret, B., Blecha, J., Tang, R., VanBrocklin, H., & Chaumeil, M. M. (2022) · Journal of Nuclear Medicine · doi:10.2967/jnumed.120.259325 · Cited by 28
“Evidence from histopathology analysis of brain tissue indicate that lesions are heterogeneous and T-cell concentrations are highly variable at sites of active demyelination (3-7).”
BackgroundViral mouse models used to study multiple sclerosis: past and present
Libbey, J. E., & Fujinami, R. S. (2021) · Archives of Virology · doi:10.1007/s00705-021-04968-5 · Cited by 26
Zhan, J., Yakimov, V., Rühling, S., Fischbach, F., Nikolova, E., Joost, S., Kaddatz, H., Greiner, T., Frenz, J., Holzmann, C., et al. (2019) · Cells · doi:10.3390/cells8111439 · Cited by 25
“For example, one post-mortem study has shown that early MS lesions are characterized by oligodendrocyte degeneration and microglia activation in the absence of overt peripheral immune cells [6].”
Backgroundp75NTR independent oligodendrocyte death in cuprizone‐induced demyelination in C57BL/6 mice
Copray, J. C. V. M., Küst, B. M., Mantingh‐Otter, I., & Boddeke, H. W. G. M. (2005) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2005.00656.x · Cited by 23
Bergner, C. G., Genc, N., Hametner, S., Franz, J., van der Meer, F., Mitkovski, M., Weber, M. S., Stoltenburg‐Didinger, G., Kühl, J., Köhler, W., et al. (2021) · Glia · doi:10.1002/glia.24042 · Cited by 23
Krauspe, B. M., Dreher, W., Beyer, C., Baumgartner, W., Denecke, B., Janssen, K., Langhans, C.-D., Clarner, T., & Kipp, M. (2015) · Journal of Molecular Neuroscience · doi:10.1007/s12031-014-0412-6 · Cited by 22
Chrzanowski, U., Bhattarai, S., Scheld, M., Clarner, T., Fallier-Becker, P., Beyer, C., Rohr, S. O., Schmitz, C., Hochstrasser, T., Schweiger, F., et al. (2019) · Neurochemistry International · doi:10.1016/j.neuint.2019.03.005 · Cited by 18
Variable sensitivity to complement-dependent cytotoxicity in murine models of neuromyelitis optica
Liu, Y., Harlow, D. E., Given, K. S., Owens, G. P., Macklin, W. B., & Bennett, J. L. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0767-4 · Cited by 17
Mitochondrial Impairment in Oligodendroglial Cells Induces Cytokine Expression and Signaling
Scheld, M., Fragoulis, A., Nyamoya, S., Zendedel, A., Denecke, B., Krauspe, B., Teske, N., Kipp, M., Beyer, C., & Clarner, T. (2019) · Journal of Molecular Neuroscience · doi:10.1007/s12031-018-1236-6 · Cited by 17
Yakimov, V., Schweiger, F., Zhan, J., Behrangi, N., Horn, A., Schmitz, C., Hochstrasser, T., & Kipp, M. (2019) · Histochemistry and Cell Biology · doi:10.1007/s00418-019-01786-4 · Cited by 17
Sabo, J. K., Aumann, T. D., Kilpatrick, T. J., & Cate, H. S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0063415 · Cited by 13
Scalabrino, G. (2022) · Biomedicines · doi:10.3390/biomedicines10040815 · Cited by 10
Metadata
- Authors
- Barnett, M. H., & Prineas, J. W.
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 2004-03-21
- Volume
- 55
- Issue
- 4
- Pages
- 458-468
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- OpenAlex
- W1987057401
- Cited by
- 1,185
- References
- 62
- FWCI
- 56.64
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.